Green Tea Extract (EGCG) — Research Profile

Clinical trials show modest weight loss of 1-2 kg over 12 weeks beyond what diet alone achieves ^[1]. Green tea extract increases 24-hour energy expenditure and fat oxidation compared to placebo ^[2]. Combined with exercise and calorie control, it provides a consistent thermogenic boost — effects are real but modest.

At standard doses (400-500 mg EGCG/day), green tea extract is safe for most people. Rare liver injury reports are associated with high-dose (>800 mg EGCG) fasted supplementation. To minimize risk: stay under 800 mg EGCG/day, take with food, and avoid combining with other hepatotoxic substances.

Studies show EGCG + caffeine is more effective for fat oxidation than EGCG alone. If you tolerate caffeine well, choose a formula that includes both. If caffeine-sensitive, decaffeinated EGCG still provides benefits, just slightly less thermogenic effect.

No trial has shown one supplement form of EGCG to outperform another for weight. What the evidence does distinguish is safety by concentration: EFSA considers EGCG from brewed green tea infusions safe at habitual 90 to 300 mg/day intakes, while the liver-enzyme signal attaches specifically to concentrated food-supplement doses of 800 mg/day or more. Capsules and tablets are also the forms most linked to the uncommon cases of liver injury, so a brewed or lower-concentration source carries a more favorable safety profile.

For weight, the proven effect is small. A Cochrane meta-analysis of trials outside Japan found a mean weight difference of only -0.04 kg versus placebo (95% CI -0.5 to 0.4) and no significant effect on maintaining weight loss. The clearest measurable action is metabolic: a controlled chamber study showed green tea extract raised 24-hour energy expenditure by about 4% and shifted fuel use toward fat, beyond what its caffeine content alone explained.

There is no established weight-loss dose. The chamber protocol that produced a thermogenic effect used 90 mg EGCG plus 50 mg caffeine three times daily, about 270 mg EGCG/day, and the weight-loss trials used a range of preparations with little pooled benefit. Whatever the target, EFSA's data indicate keeping supplemental EGCG below 800 mg/day to avoid liver enzyme elevations.

Timing has not been directly compared for weight or metabolic outcomes, so no time of day is evidence-based. The thermogenic study simply split doses across the three main meals. Because these extracts contain caffeine, late-day dosing can disturb sleep and add to caffeine's blood-pressure effect, which is a practical reason to favor earlier in the day.

The most commonly reported supplement side effects are nausea, constipation, abdominal discomfort, and increased blood pressure. The serious but uncommon concern is liver injury, which EFSA linked to supplemental EGCG at 800 mg/day or above; people with a specific immune-related gene variant, an estimated 5 to 15 percent of Americans, are at higher risk.

Yes. NCCIH cites documented interactions in which high-dose green tea lowers the blood levels and effectiveness of the beta-blocker nadolol, reduces levels of the statin atorvastatin, and interacts with the osteoporosis drug raloxifene. Its caffeine content can also compound other stimulants, so high-dose extracts are a poor fit alongside these medications.

Green tea extract is marketed mainly for weight loss, but pooled trial evidence shows minimal, clinically unimportant weight change, so anyone expecting meaningful fat loss from it alone is likely to be disappointed. It is most reasonable for people simply wanting a modest catechin and caffeine source. It should be avoided by those with liver disease or elevated liver enzymes and by anyone taking nadolol, atorvastatin, or raloxifene given the documented interactions.

The metabolic effect is essentially immediate: in a 24-hour chamber study, green tea extract raised energy expenditure and fat oxidation the same day it was taken. Weight change is a different story, since pooled trials outside Japan found a mean difference of only -0.04 kg versus placebo over roughly 12 weeks, an amount the authors judged too small to be clinically important. Expect any change on the scale to be minor even after 8 to 12 weeks.

Long-term safety depends heavily on dose. EFSA concluded that green tea catechins taken as a supplement at 800 mg EGCG/day or more produce a statistically significant rise in liver transaminases, whereas EGCG from brewed tea at habitual European intakes of 90 to 300 mg/day is generally considered safe. Because liver injury from concentrated extracts, though uncommon, is documented and an estimated 5 to 15 percent of people carry a gene variant that raises their risk, sustained high-dose use is not established as safe and justifies periodic liver monitoring.

Yes. EFSA identified 800 mg EGCG/day from supplements as the intake at which serum transaminases rise significantly, and supplement products span a wide 5 to 1,000 mg EGCG/day range, so it is possible to reach the hepatotoxic zone. Reported over-intake effects range from nausea and stomach upset to rare but serious acute liver injury.

The main caution with combinations is additive load rather than a specific nutrient clash. Stacking multiple green tea, EGCG, or catechin-based fat-burner products can push total EGCG toward the 800 mg/day level EFSA linked to liver enzyme elevations. Because these extracts also contain caffeine, pairing them with other stimulants compounds effects like raised blood pressure, and no controlled trials establish added benefit from any specific EGCG supplement combination.

Choose a product that states its standardized EGCG (or total catechin) content per serving, since supplement EGCG doses vary enormously, from 5 to 1,000 mg/day across products. Total up the EGCG you would take daily and keep it well below the 800 mg/day supplement threshold EFSA tied to liver transaminase elevations. Prioritize third-party purity and potency testing, because concentrated capsules and tablets, not brewed tea, are the forms most associated with the rare cases of liver injury.